Webcast
*Wednesday, May 19, 2021 at 11am EDT| 8am PDT| 4pm BST| 5pm CEST* The selection of single-use materials for novel gene therapies, as well as the material’s commercial viability, is crucial especially for those used in storage and cryogenic operations. Learn about key product contact material and process compatibility requirements during this webcast. *On Demand Until May 19, 2022*
Register free: https://www.biopharminternational.com/bp_w/scale
Event Overview:
Despite the industry challenges posed by the COVID-19 pandemic, novel gene therapy development has adapted and is returning to the spotlight. With this comes a refocus on the selection of optimal single-use materials for early-phase regulatory compliance, which is particularly important for materials used in storage and cryogenic operations. To address the current concerns of manufacturability, however, a material’s commercial viability should also be discerned to ensure process economics at scale. This webinar will allow manufacturing and process professionals to:
Key Learning Objectives:
Speakers:
Muhammad Siddiqui, Cold Chain Applications Engineer, Entegris Inc
Time and Date:
Wednesday, May 19, 2021 at 11am EDT| 8am PDT| 4pm BST| 5pm CEST
Register free: https://www.biopharminternational.com/bp_w/scale